Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review.

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

Alongside the leadership change, Kenvue revealed that its Board had previously initiated a comprehensive review of strategic alternatives and established a Strategic Review Committee. The review will ...

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

Kenvue moved its headquarters from Skillman to the new Summit site.. Key details of the Summit HQ include: . 290,000 square feet, including a 100,000-square-foot, state-of-the-art Science and ...

When fully complete, the new campus will house some 3,000 employees. A new beginning “Today, I am very excited to mark a major milestone for our future,” said Kenvue CEO Thibaut Mongon. “One ...

Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth after its solid debut on the public market Thursday. Kenvue, J&J's consumer health business spinoff, has an ...